New England Journal of Medicine Publishes New Data for Genentech's Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis

5 months ago 24
Read Entire Article
  1. Homepage
  2. Finance
  3. New England Journal of Medicine Publishes New Data for Genentech's Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis

Related

Wegovy maker Novo Nordisk to reduce costs after $95 billion stock loss

Wegovy maker Novo Nordisk to reduce costs after $95 billion ...

13 minutes ago 0
Siemens Energy targets upper end of 2025 outlook on strong US demand

Siemens Energy targets upper end of 2025 outlook on strong U...

13 minutes ago 0
Sampo launches €200 million share buyback program

Sampo launches €200 million share buyback program

13 minutes ago 0

Trending

1. janet jackson
2. grok imagine
3. addison rae
4. sam howell
5. padres schedule
6. buccaneers show
7. padres standings
8. ramon laureano
9. shakira
10. kat sadler

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

6 months ago 423
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 204
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 184
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 149
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

6 months ago 144
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved